Alkem Laboratories Share Price

ABOUT Alkem Laboratories

• Industry Biotechnology & Drugs
• ISIN INE540L01014
• BSE Code 539523
• NSE Code ALKEM

Alkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. It has a portfolio of more than 800 brands in India. The Company also has a presence in more than 40 international markets, with the United States being its key focus market. Its offerings include therapies, Rx products and Alkem generic. Its therapy offerings include anti-infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology and urology. Its product portfolio also includes mega-brands such as Clavam, Pan, Pan-D, and Taxim-O. Under the Alkem Generics cluster there are four divisions: Futura, Maxxio, Novokem and Alkem Healthcare.

MANAGEMENT

• Basudeo Singh Executive Chairman of the Board
• Vikas Gupta Chief Executive Officer
• Nitin Agrawal President - Finance, Chief Financial Officer
• Manish Narang President - Legal, Chief Compliance Officer, Company Secretary
• Sandeep Singh Managing Director, Executive Director
• Madhurima Singh Executive Director
• Mritunjay Singh Executive Director
• Sarvesh Singh Executive Director
• Srinivas Singh Executive Director